Oncotelic Therapeutics Inc
(OTLC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1993 | 12-1992 | 12-1991 | 12-1990 | 12-1989 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,517 | 165 | 416 | 416 | N/A |
| Other current assets | 0 | 0 | 1 | 1 | 0 |
| TOTAL | $7,517 | $165 | $417 | $417 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 24 | 18 | 0 | 0 | N/A |
| Other Non-Current Assets | 10 | 10 | 0 | 0 | 0 |
| TOTAL | $34 | $28 | $N/A | $N/A | $N/A |
| Total Assets | $7,551 | $192 | $417 | $417 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 152 | 163 | 99 | 99 | 0 |
| Other current liabilities | 158 | 0 | 100 | 100 | N/A |
| TOTAL | $310 | $163 | $199 | $199 | $N/A |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $310 | $163 | $199 | $199 | $N/A |
| Shareholders' Equity | |||||
| Common Shares | 50 | 29 | 19 | 19 | N/A |
| Retained earnings | -4,842 | -2,822 | -1,194 | -1,194 | N/A |
| Other shareholders' equity | 0 | -361 | 0 | 0 | 0 |
| TOTAL | $7,241 | $29 | $219 | $219 | $N/A |
| Total Liabilities And Equity | $7,551 | $192 | $417 | $417 | $0 |